Actuate Therapeutics (ACTU) Times Interest Earned (2023 - 2025)
Actuate Therapeutics (ACTU) posted quarterly Times Interest Earned of -$84.07 for Q4 2025, down 167.05% year-over-year from $125.38 in Q4 2024, and up 92.22% quarter-over-quarter from -$1080.9 in Q3 2025.
Actuate Therapeutics (ACTU) Times Interest Earned (2023 - 2025) Analysis & Trends
Actuate Therapeutics (ACTU) has reported Times Interest Earned for 3 consecutive years, with -$84.07 the latest figure, recorded in Q4 2025.
- In Q4 2025, Times Interest Earned fell 167.05% year-over-year to -$84.07; the TTM figure through Dec 2025 stood at -$317.03 (down 148.73% YoY), while the FY2025 annual figure was -$13.49, down 1921.94% from the prior year.
- Times Interest Earned grew to -$84.07 in Q4 2025 per ACTU's latest filing, from -$1080.9 in the prior quarter.
- Across five years, Times Interest Earned topped out at $125.38 in Q4 2024 and bottomed at -$1545.7 in Q3 2024.
- Historically, Times Interest Earned has averaged -$1046.4 across 3 years, with a median of -$1179.2 in 2025.
- Annual changes were most pronounced in 2024 — Times Interest Earned jumped 108.34% — and 2025, when it tumbled 167.05%.
- Actuate Therapeutics' Times Interest Earned stood at -$1504.1 in 2023, then surged by 108.34% to $125.38 in 2024, then sank by 167.05% to -$84.07 in 2025.
- Business Quant data shows ACTU's Times Interest Earned at -$84.07 in Q4 2025, -$1080.9 in Q3 2025, and -$1179.2 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Actuate Therapeutics | 30.08 Mn | 30.08 Mn | - | -969.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -84.07 |
| Sep 30, 2025 | -1,080.86 |
| Jun 30, 2025 | -1,179.15 |
| Mar 31, 2025 | -1,257.28 |
| Dec 31, 2024 | 125.38 |
| Sep 30, 2024 | -1,545.69 |
| Jun 30, 2024 | -1,070.81 |
| Mar 31, 2024 | -1,531.37 |
| Dec 31, 2023 | -1,504.08 |
| Sep 30, 2023 | -1,279.27 |
| Jun 30, 2023 | -1,103.20 |